109 related articles for article (PubMed ID: 9844901)
1. [The use of enzymes in treating patients with malignant lymphoma with a large tumor mass].
Gubareva AA
Lik Sprava; 1998 Aug; (6):141-3. PubMed ID: 9844901
[TBL] [Abstract][Full Text] [Related]
2. [Systemic enzyme therapy with the preparation Wobe-Mugos E in the combined treatment of lung cancer patients].
Smolanka II
Lik Sprava; 2000; (5):121-3. PubMed ID: 11031472
[TBL] [Abstract][Full Text] [Related]
3. [Application of systemic enzyme therapy in combined treatment of patients with pulmonary cancer and malignant thymoma].
Hanul VL; Smolanka II; Ponomar'ova OV
Klin Khir; 2000 Jun; (6):17-9. PubMed ID: 11288269
[TBL] [Abstract][Full Text] [Related]
4. [The favorable effect of hydrolytic enzymes in the treatment of immunocytomas and plasmacytomas].
Sakalová A; Mikulecký M; Holománová D; Langner D; Ransberger K; Stauder G; Mistrík M; Gazová S; Chabronová I; Benzová M
Vnitr Lek; 1992 Sep; 38(9):921-9. PubMed ID: 1481392
[TBL] [Abstract][Full Text] [Related]
5. [Wobe-Mugos: a proteolytic enzyme combination for tumor therapy. Documentation No. 7].
Schweiz Rundsch Med Prax; 1987 Dec; 76(51):1430-2. PubMed ID: 3326110
[No Abstract] [Full Text] [Related]
6. Double-blind pilot-study on the efficacy of enzyme therapy in advanced colorectal cancer.
Popiela T; Kulig J; Kłek S; Wachol D; Bock PR; Hanisch J
Przegl Lek; 2000; 57 Suppl 5():142. PubMed ID: 11202281
[TBL] [Abstract][Full Text] [Related]
7. The role of Wobe-Mugos in reducing acute sequele of radiation in head and neck cancers--a clinical phase-III randomized trial.
Kaul R; Mishra BK; Sutradar P; Choudhary V; Gujral MS
Indian J Cancer; 1999; 36(2-4):141-8. PubMed ID: 10921218
[TBL] [Abstract][Full Text] [Related]
8. [Effect of the preparation Wobe-Mugos E on parameters of the antioxidant defence system and morphofunctional erythrocyte status in patients with chronic obstructive bronchitis].
Kolomoiets' MIu; Kovalenko SV; Todoriko LD
Lik Sprava; 2000 Sep; (6):100-4. PubMed ID: 11478274
[TBL] [Abstract][Full Text] [Related]
9. Enzyme therapy in patients with advanced colorectal cancer.
Popiela T; Kulig J; Kłek S; Wachol D; Bock PR; Hanisch J
Przegl Lek; 2000; 57 Suppl 5():138-9. PubMed ID: 11202278
[No Abstract] [Full Text] [Related]
10. Local transrectal enzymatic treatment for chronic nonbacterial prostatitis and prostatodynia: initial clinical experience.
Kerbl K; Zisch R
Tech Urol; 2000 Mar; 6(1):22-5. PubMed ID: 10708143
[TBL] [Abstract][Full Text] [Related]
11. [The effect of the preparation Wobe-Mugos E on the functional and biochemical status of the kidneys in the polyuric stage of sublimate-induced nephropathy].
Rohovyĭ IuIe; Myslyts'kyĭ VF; Filipova LO; Shapovalov VP; Mahalias MV; Maĭkan RI; Chortyk IuB
Fiziol Zh (1994); 2000; 46(3):51-6. PubMed ID: 11059387
[TBL] [Abstract][Full Text] [Related]
12. Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial.
Martin T; Uhder K; Kurek R; Roeddiger S; Schneider L; Vogt HG; Heyd R; Zamboglou N
Radiother Oncol; 2002 Oct; 65(1):17-22. PubMed ID: 12413670
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Wobe-Mugos E for reduction of oral mucositis after radiotherapy : results of a prospective, randomized, placebo-controlled, triple-blind phase III multicenter study.
Dörr W; Herrmann T;
Strahlenther Onkol; 2007 Mar; 183(3):121-7. PubMed ID: 17340069
[TBL] [Abstract][Full Text] [Related]
14. [Systemic enzymotherapy as a method of prophylaxis of postradiation complications in oncological patients].
Hubarieva HO; Kindzel's'kyĭ LP; Ponomar'ova OV; Udatova TV; Shpil'ova SI; Smolanka II; Korovin SI; Ivankin VS
Lik Sprava; 2000; (7-8):94-100. PubMed ID: 16786662
[TBL] [Abstract][Full Text] [Related]
15. [Modification of liver parameters by adjuvant administration of proteolytic enzymes following chemotherapy in patients with ovarian carcinoma].
Lahousen M
Wien Med Wochenschr; 1995; 145(24):663-8. PubMed ID: 8585220
[TBL] [Abstract][Full Text] [Related]
16. [Radiation and complex therapy of malignant lymphomas (review of the literature)].
Zolotkov AG; Beliakova IA; Pereslegin OI
Vestn Rentgenol Radiol; 1986; (2):70-5. PubMed ID: 3521063
[No Abstract] [Full Text] [Related]
17. [Enzyme therapy--an alternative in treatment of herpes zoster. A controlled study of 192 patients].
Billigmann P
Fortschr Med; 1995 Feb; 113(4):43-8. PubMed ID: 7713467
[TBL] [Abstract][Full Text] [Related]
18. [The effect of vilozen on the immune status of erysipelas patients and the prospects for its use for the immune rehabilitation of convalescents].
Frolov VM; Peresadin NA; Pinskiĭ LL; Korobka IuN
Lik Sprava; 1992; (11-12):102-4. PubMed ID: 1292201
[No Abstract] [Full Text] [Related]
19. [The use of propes in the combined treatment of malignant lymphomas].
Kindzel'skiĭ LP; Gubareva AA; Tomilina NA; Sivkovich SA; Ponomareva OV; Naĭshtetik VIa
Lik Sprava; 1997; (4):146-7. PubMed ID: 9471360
[TBL] [Abstract][Full Text] [Related]
20. [Wobenzym in the combined pathogenetic therapy of chronic urethrogenic prostatitis].
Martynenko AV
Lik Sprava; 1998 Aug; (6):118-20. PubMed ID: 9844894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
